We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
Cap. Flow
-$149M
Cap. Flow %
-1.86%
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$82.6M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$56.2M
3
TBBB icon
BBB Foods
TBBB
+$39.9M
4
NTRA icon
Natera
NTRA
+$35.9M
5
LOAR icon
Loar Holdings
LOAR
+$29.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$171M
2
NVDA icon
NVIDIA
NVDA
+$107M
3
INTC icon
Intel
INTC
+$54.3M
4
DNLI icon
Denali Therapeutics
DNLI
+$24.1M
5
NFLX icon
Netflix
NFLX
+$20.2M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 19.21%
3 Healthcare 16.85%
4 Communication Services 13.51%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKTX icon
201
MarketAxess Holdings
MKTX
$5.71B
$1.12M 0.01%
5,588
+1
+0% +$206
AZUL
202
DELISTED
Azul
AZUL
$1.09M 0.01%
272,560
-239,802
-47% -$1.41M
TGTX icon
203
TG Therapeutics
TGTX
$7.07B
$1.08M 0.01%
+60,673
New +$968K
SILK
204
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.06M 0.01%
39,372
+4,440
+13% +$92.4K
SKE
205
Skeena Resources
SKE
$3.32B
$1.03M 0.01%
192,511
-193,972
-50% -$914K
EXAS
206
DELISTED
Exact Sciences
EXAS
$998K 0.01%
23,631
-420
-2% -$23.1K
VRTX icon
207
Vertex Pharmaceuticals
VRTX
$120B
$969K 0.01%
2,067
+273
+15% +$118K
HWM icon
208
Howmet Aerospace
HWM
$114B
$882K 0.01%
11,359
-36
-0.3% -$2.73K
CLH icon
209
Clean Harbors
CLH
$16.5B
$869K 0.01%
3,842
+2
+0.1% +$419
AMAT icon
210
Applied Materials
AMAT
$408B
$853K 0.01%
+3,613
New +$776K
ECHO
211
EchoStar
ECHO
$24.5B
$841K 0.01%
47,210
-353
-0.7% -$5.85K
SNAP icon
212
Snap
SNAP
$8.39B
$827K 0.01%
49,798
-38
-0.1% -$545
RARE icon
213
Ultragenyx Pharmaceutical
RARE
$2.46B
$819K 0.01%
19,927
+2,504
+14% +$107K
FINW icon
214
FinWise Bancorp
FINW
$196M
$776K 0.01%
76,011
-125,077
-62% -$1.28M
AZEK
215
DELISTED
The AZEK Co
AZEK
$774K 0.01%
18,368
+153
+0.8% +$7.08K
CYTK icon
216
Cytokinetics
CYTK
$10.2B
$749K 0.01%
13,830
-221
-2% -$13.3K
PM icon
217
Philip Morris
PM
$294B
$743K 0.01%
7,332
-108
-1% -$10.6K
IAUX
218
i-80 Gold Corp
IAUX
$1.13B
$724K 0.01%
670,115
-14,518
-2% -$17K
SSNC icon
219
SS&C Technologies
SSNC
$18.5B
$659K 0.01%
10,518
-38,862
-79% -$2.41M
RIG icon
220
Transocean
RIG
$5.71B
$639K 0.01%
119,519
-24,396
-17% -$141K
DYN icon
221
Dyne Therapeutics
DYN
$4.67B
$619K 0.01%
+17,546
New +$510K
ACMR icon
222
ACM Research
ACMR
$5.38B
$612K 0.01%
26,530
-191
-0.7% -$4.83K
ETN icon
223
Eaton
ETN
$168B
$604K 0.01%
1,927
-1
-0.1% -$323
CRNX icon
224
Crinetics Pharmaceuticals
CRNX
$8.87B
$575K 0.01%
+12,836
New +$593K
ENFN
225
DELISTED
Enfusion, Inc.
ENFN
$556K 0.01%
65,270
+10,351
+19% +$94.7K
7 8
9
10 11

Similar funds

AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
  • Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
  • Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
  • Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
  • Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.